[go: up one dir, main page]

HK1170487A1 - Bicyclic compound and use thereof for medical purposes - Google Patents

Bicyclic compound and use thereof for medical purposes

Info

Publication number
HK1170487A1
HK1170487A1 HK12111269.7A HK12111269A HK1170487A1 HK 1170487 A1 HK1170487 A1 HK 1170487A1 HK 12111269 A HK12111269 A HK 12111269A HK 1170487 A1 HK1170487 A1 HK 1170487A1
Authority
HK
Hong Kong
Prior art keywords
medical purposes
bicyclic compound
bicyclic
compound
medical
Prior art date
Application number
HK12111269.7A
Other languages
Chinese (zh)
Inventor
Tohru Kambe
Toru Maruyama
Shinsaku Yamane
Satoshi Nakayama
Kousuke Tani
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of HK1170487A1 publication Critical patent/HK1170487A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/10Ophthalmic agents for accommodation disorders, e.g. myopia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902Method of implanting
    • Y10S623/905Eye

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Image Processing (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Ink Jet Recording Methods And Recording Media Thereof (AREA)
HK12111269.7A 2009-07-28 2012-11-08 Bicyclic compound and use thereof for medical purposes HK1170487A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009175246 2009-07-28
PCT/JP2010/062587 WO2011013651A1 (en) 2009-07-28 2010-07-27 Bicyclic compound and use thereof for medical purposes

Publications (1)

Publication Number Publication Date
HK1170487A1 true HK1170487A1 (en) 2013-03-01

Family

ID=43529306

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111269.7A HK1170487A1 (en) 2009-07-28 2012-11-08 Bicyclic compound and use thereof for medical purposes

Country Status (21)

Country Link
US (10) US8614340B2 (en)
EP (2) EP2653468B1 (en)
JP (3) JP5652397B2 (en)
KR (1) KR101768235B1 (en)
CN (1) CN102498105B (en)
AU (1) AU2010279183B2 (en)
BR (1) BR112012001797B1 (en)
CA (1) CA2767083C (en)
DK (2) DK2460801T3 (en)
ES (2) ES2567328T3 (en)
HK (1) HK1170487A1 (en)
HU (1) HUE028874T2 (en)
IL (1) IL217342A (en)
MX (1) MX2012000889A (en)
NZ (1) NZ597626A (en)
PL (2) PL2653468T3 (en)
PT (1) PT2460801E (en)
RU (1) RU2540330C2 (en)
TW (1) TWI466877B (en)
WO (1) WO2011013651A1 (en)
ZA (1) ZA201200797B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2567328T3 (en) * 2009-07-28 2016-04-21 Ono Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
EP2669279B1 (en) * 2011-01-27 2017-01-11 ONO Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
ES2581852T3 (en) 2011-01-27 2016-09-07 Ono Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
US9944217B2 (en) 2013-02-11 2018-04-17 Ferno-Washington, Inc. Equipment mounting system
EP3112362B1 (en) * 2014-02-27 2018-09-26 ONO Pharmaceutical Co., Ltd. Compound exhibiting selective ep2 agonist activity
WO2017014315A1 (en) * 2015-07-23 2017-01-26 小野薬品工業株式会社 Compound having ep2 agonistic activity
IL295050A (en) * 2016-04-01 2022-09-01 Recurium Ip Holdings Llc Estrogen receptor modulators
JP6954282B2 (en) * 2016-06-30 2021-10-27 小野薬品工業株式会社 Method for producing bicyclic compound
WO2019124489A1 (en) * 2017-12-21 2019-06-27 参天製薬株式会社 Medicament comprising combination of sepetaprost and ep2 agonist
ES2972934T3 (en) 2017-12-21 2024-06-17 Santen Pharmaceutical Co Ltd Combination of sepetaprost and ripasudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension
TWI809021B (en) * 2017-12-21 2023-07-21 日商小野藥品工業股份有限公司 GLAUCOMA THERAPEUTIC AGENT CONTAINING FP AGONIST AND β BLOCKER
CN116159601B (en) * 2019-03-15 2024-07-23 博瑞生物医药(苏州)股份有限公司 Eribulin intermediate and preparation method thereof
WO2021051149A1 (en) * 2019-09-19 2021-03-25 Polyactiva Pty Ltd Biodegradable drug-polymer conjugate
CN113121443B (en) 2019-12-31 2024-07-09 财团法人工业技术研究院 Beta-amino acid derivatives, kinase inhibitors and pharmaceutical compositions containing them and their use
WO2021145356A1 (en) * 2020-01-15 2021-07-22 参天製薬株式会社 Drug composition for treating nearsightedness, preventing nearsightedness, and/or minimizing progression of nearsightedness
CN115768433A (en) * 2020-08-13 2023-03-07 参天制药株式会社 Pharmaceutical preparation containing ospepristone
CN119072313A (en) 2022-04-22 2024-12-03 参天制药株式会社 Ophthalmic composition containing spepprostil

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US425417A (en) * 1890-04-15 Wall-paper exhibitor
JPS5411311B2 (en) * 1973-08-11 1979-05-14
IL51189A (en) 1976-02-04 1985-08-30 Upjohn Co Prostaglandin analogs
FR2344285A1 (en) * 1976-03-19 1977-10-14 Roussel Uclaf NEW LACTONS DERIVED FROM CYCLOPENTANOL, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FI71138C (en) 1976-12-31 1986-11-24 Erba Farmitalia FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ACTIVE BISYCLISKA PROSTAGLANDINER
US4490548A (en) 1977-04-19 1984-12-25 The Upjohn Company Enlarged-hetero-ring prostacyclin analogs
US4490537A (en) 1977-04-19 1984-12-25 The Upjohn Company Enlarged-hetero-ring prostacyclin analogs
US4169841A (en) * 1977-04-19 1979-10-02 The Upjohn Company Alkenyl-substituted 9-deoxy-6,9-α-epoxymethano-PG analogs
US4209615A (en) * 1977-04-19 1980-06-24 The Upjohn Company Phenyl-substituted 9-deoxy-6,9α-epoxymethano-PG analogs
CA1184906A (en) 1977-04-19 1985-04-02 Roy A. Johnson 9-deoxy-5,9-epoxy-prostaglandins
JPS5573678A (en) 1978-11-29 1980-06-03 Ono Pharmaceut Co Ltd Simultated compound of thio-prostaglandin i1, its preparation and drug composition containing it as active ingredient
DE2947526A1 (en) 1978-11-29 1980-06-12 Ono Pharmaceutical Co PROSTACYCLIN ANALOGS
JPS6468367A (en) * 1987-09-08 1989-03-14 Ono Pharmaceutical Co Novel bicyclic ethers or lactones
CN1268623C (en) 1999-10-15 2006-08-09 苏坎波公司 Novel composition and method or stabilizing same
JP5037780B2 (en) 2003-05-23 2012-10-03 三菱化学株式会社 Active energy ray-curable composition and hard coat film
US7906552B2 (en) * 2004-08-10 2011-03-15 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
CA2657967A1 (en) * 2006-06-20 2007-12-27 Allergan, Inc. Cyclopentane derivatives as antiglaucoma agents
JP5573678B2 (en) 2008-12-10 2014-08-20 コニカミノルタ株式会社 Method for manufacturing organic electroluminescent element, organic electroluminescent element
JP5384959B2 (en) 2009-01-28 2014-01-08 セミコンダクター・コンポーネンツ・インダストリーズ・リミテッド・ライアビリティ・カンパニー Electronic circuit
US9280875B2 (en) 2009-03-06 2016-03-08 Zynga Inc. Virtual playing chips in a multiuser online game network
ES2567328T3 (en) * 2009-07-28 2016-04-21 Ono Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
CN102336754B (en) 2010-07-15 2017-04-12 浙江奥翔药业股份有限公司 Method for synthesizing entecavir and intermediate compound thereof
ES2581852T3 (en) 2011-01-27 2016-09-07 Ono Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
EP2669279B1 (en) 2011-01-27 2017-01-11 ONO Pharmaceutical Co., Ltd. Bicyclic compound and use thereof for medical purposes
US9689114B2 (en) * 2014-08-07 2017-06-27 Georgia-Pacific Chemicals Llc Strengthening resins for paper products
JP6954282B2 (en) * 2016-06-30 2021-10-27 小野薬品工業株式会社 Method for producing bicyclic compound

Also Published As

Publication number Publication date
EP2460801A4 (en) 2013-01-02
US8614340B2 (en) 2013-12-24
PL2653468T3 (en) 2016-08-31
US20160287551A1 (en) 2016-10-06
US20250099419A1 (en) 2025-03-27
US20200093781A1 (en) 2020-03-26
BR112012001797A2 (en) 2017-05-16
EP2653468B1 (en) 2016-02-24
IL217342A0 (en) 2012-02-29
CA2767083C (en) 2017-05-16
US20120122964A1 (en) 2012-05-17
US20180116995A1 (en) 2018-05-03
ZA201200797B (en) 2012-10-31
JP2016188217A (en) 2016-11-04
MX2012000889A (en) 2012-02-13
AU2010279183A1 (en) 2012-02-02
KR20120038986A (en) 2012-04-24
PT2460801E (en) 2014-08-29
JP6149975B2 (en) 2017-06-21
PL2460801T3 (en) 2014-11-28
US20140073676A1 (en) 2014-03-13
CN102498105B (en) 2014-04-02
JP2015052011A (en) 2015-03-19
RU2540330C2 (en) 2015-02-10
US10201520B2 (en) 2019-02-12
HUE028874T2 (en) 2017-01-30
US12201603B2 (en) 2025-01-21
JPWO2011013651A1 (en) 2013-01-07
EP2460801B1 (en) 2014-06-25
EP2653468A1 (en) 2013-10-23
CA2767083A1 (en) 2011-02-03
US9388157B2 (en) 2016-07-12
ES2567328T3 (en) 2016-04-21
EP2460801A1 (en) 2012-06-06
US11617733B2 (en) 2023-04-04
NZ597626A (en) 2013-03-28
TW201109311A (en) 2011-03-16
IL217342A (en) 2016-03-31
US20190111019A1 (en) 2019-04-18
US8962868B2 (en) 2015-02-24
AU2010279183B2 (en) 2015-10-29
BR112012001797B1 (en) 2020-04-07
US9889114B2 (en) 2018-02-13
RU2012107109A (en) 2013-09-10
JP5652397B2 (en) 2015-01-14
CN102498105A (en) 2012-06-13
DK2653468T3 (en) 2016-06-06
US20230190698A1 (en) 2023-06-22
WO2011013651A1 (en) 2011-02-03
US20150112079A1 (en) 2015-04-23
TWI466877B (en) 2015-01-01
US10940134B2 (en) 2021-03-09
US20210169842A1 (en) 2021-06-10
JP5935857B2 (en) 2016-06-15
KR101768235B1 (en) 2017-08-14
DK2460801T3 (en) 2014-09-22
ES2500067T3 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
HK1170487A1 (en) Bicyclic compound and use thereof for medical purposes
HK1165793A1 (en) Indolizine derivative and use thereof for medical purposes
EP2464227A4 (en) Compounds and methods of use thereof
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
AP2013006947A0 (en) Compounds and their use
GB0920258D0 (en) New medical agents and use thereof
ZA201205057B (en) Fungicidal compounds and methods of their use
ZA201201676B (en) Azetidinone compounds and medical use thereof
HK1184779A1 (en) Novel compound and medical use thereof
GB201011411D0 (en) Therapeutic compounds and their use
GB0902173D0 (en) Compounds and their use
EP2615094A4 (en) Sesterterpene compounds and use thereof
IL220621A0 (en) Anticoagulant compounds and their use
GB0908425D0 (en) Medical use
HK1131039A1 (en) Pharmaceutical use of sophoricoside
GB0913300D0 (en) Therapeutic compounds and their use
GB201001364D0 (en) New compounds and medical uses
GB201001370D0 (en) New compounds and medical uses
GB201001376D0 (en) New compounds and medical uses
GB201001383D0 (en) New compounds and medical uses
GB0905231D0 (en) Compounds and their use
GB0902013D0 (en) Novel compounds and their use
GB0922098D0 (en) Therapeutic use
GB201005511D0 (en) Compounds and their use
GB201000305D0 (en) Compounds and their use